Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01482351 · ClinicalTrials.gov registry record · NA
Mild Cognitive Impairment and Obstructive Sleep Apnea
A NA study, sponsored by George Mason University.
- Completed
- Registry status
- NA
- Development phase
- 54
- Enrollment target
NCT01482351 is a NA study that has completed, run by George Mason University. The registered enrollment target is 54 participants.
The verdict
NCT01482351, a NA study, has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- NA
- Development phase
- 54 participants
- Enrollment target
Study Summary
Obstructive sleep apnea (OSA) has been linked to increased risk for Alzheimer's disease (AD), but little prospective evidence exists on the effects of OSA treatment in preclinical AD. The objective was to determine if CPAP treatment adherence, controlling for baseline differences, predicts cognitive and everyday function after 1 year in older adults with MCI and to determine effect sizes for a larger trial. The aim of the Mild Cognitive Impairment and Obstructive Sleep Apnea (Memories 1) trial was to determine whether CPAP treatment adherence, controlling for any baseline differences in OSA severity, ApoE4, and other previously identified demographic and patient factors, might predict cognitive and everyday function after 1 year in older adults with amnestic MCI.
Interventions
- BEHAVIORAL CPAP adherence intervention
- BEHAVIORAL Attention control intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 54 participants |
| Start Date | 2012-09 |
| Est. Completion | 2014-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01482351
The ClinicalTrials.gov registry entry for NCT01482351 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 54 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is George Mason University, which has 25 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which CPAP adherence intervention is the first listed.
NCT01482351 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01482351 about?
NCT01482351 is a clinical study titled "Mild Cognitive Impairment and Obstructive Sleep Apnea". Obstructive sleep apnea (OSA) has been linked to increased risk for Alzheimer's disease (AD), but little prospective evidence exists on the effects of OSA treatment in preclinical AD. The objective was to determine if CPAP treatment adherence, controlling for baseline differences, predicts cognitive...
What is the current status of trial NCT01482351?
This trial is currently completed. It is a NA study. The enrollment target is 54 participants. The study started on 2012-09. Estimated completion is 2014-12.
What interventions are being tested in trial NCT01482351?
The interventions under investigation include: CPAP adherence intervention (BEHAVIORAL), Attention control intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT01482351?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.